Since altered IgG glycosylation is a common feature of inflammatory conditions, we next tested whether COVID-19-related total and anti-S IgG1 glycosylation alterations correlate with changes in CRP and plasma anti-S IgG concentration in the course of COVID-19. The gene discussed is CRP; the disease is COVID-19.